Olanzapine Tablet, Orally Disintegrating
Product Images NDC 64380-175
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64380-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 02)
Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 03)
Principal Display Panel 15 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 04)
Principal Display Panel 20 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.